无创呼吸机治疗冠心病致急性心力衰竭的研究

Noninvasive Ventilator in the Treatment of Acute Heart Failure Caused by Coronary Heart Disease

目的:分析无创呼吸机治疗冠心病致急性心力衰竭的临床效果。方法:选取2018年9月~2020年9月本院收治的90例冠心病致急性心力衰竭患者为研究对象,基于治疗方案的不同将患者分为两组。对照组患者采用常规治疗措施,研究组在对照组患者治疗基础中应用无创呼吸机进行治疗。观察两组患者的治疗有效率以及血氧分压、二氧化碳分压和平均动脉压。结果:研究组患者总治疗有效率为82.22%(37/45),显著高于对照组的51.11%(23/45),P<0.05。治疗后研究组患者的血氧分压、二氧化碳分压和平均动脉压分别为(94.33±6.43)mmHg、(32.58±4.17)mmHg和(141.65±11.87)mmHg,均显著优于对照组的(87.60±5.52)mmHg、(43.51±4.50)mmHg和(162.04±12.04)mmHg,P<0.05。结论:对冠心病致急性心力衰竭应用无创呼吸机进行治疗可以显著改善治疗效果。

Objective:To analyze the clinical effect of noninvasive ventilator in the treatment of acute heart failure caused by coronary heart disease.Methods:90 patients with acute heart failure caused by coronary heart disease in our hospital from September 2018 to September 2020 were selected as the research objects,and the patients were divided into two groups based on different treatment schemes.The control group patients were treated with conventional treatment measures,and the study group was treated with noninvasive ventilator on the basis of the treatment of the control group.The therapeutic efficacy,the blood oxygen partial pressure,carbon dioxide partial pressure and average arterial pressure were observed.Results:The total effective rate of the study group was 82.22%(37/45),which was significantly higher than 51.11%(23/45)of the control group(P<0.05).The blood oxygen partial pressure,carbon dioxide partial pressure and average arterial pressure of the study group were(94.33±6.43)mmHg,(32.58±4.17)mmHg and(141.65±11.87)mmHg,respectively,which were significantly better than those of the control group(87.60±5.52)mmHg,(43.51±4.50)mmHg and(162.04±12.04)mmHg,P<0.05.Conclusion:The application of noninvasive ventilator in the treatment of acute heart failure caused by coronary heart disease can significantly improve the therapeutic effect.